[1]焦富成.阿加曲班联合参芎葡萄糖治疗进展性脑梗死35例[J].西部中医药,2014,27(02):112-113.
 JIAO Fucheng.Argatroban and ShenXiong Glucose for 35 Cases of Progressive Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(02):112-113.
点击复制

阿加曲班联合参芎葡萄糖治疗进展性脑梗死35例
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
27
期数:
2014年02期
页码:
112-113
栏目:
报道·衷中参西
出版日期:
2014-02-15

文章信息/Info

Title:
Argatroban and ShenXiong Glucose for 35 Cases of Progressive Cerebral Infarction
文章编号:
1004-6852(2014)02-0112-02
作者:
焦富成
庆阳市人民医院,甘肃 庆阳 745000
Author(s):
JIAO Fucheng
Qingyang Municipal People′s Hospital, Qingyang 745000, China
关键词:
脑梗死进展性阿加曲班参芎葡萄糖
Keywords:
cerebral infarction progressive Argatroban ShenXiong glucose
分类号:
R743.32
文献标志码:
B
摘要:
目的:观察阿加曲班联合参芎葡萄糖治疗进展性脑梗死的临床疗效。方法:将70例进展性脑梗死患者随机分为治疗组和对照组各35例,治疗组给予阿加曲班和参芎葡萄糖联合常规治疗,对照组给予常规治疗,疗程为14天。观察2组治疗前、后美国国立卫生院卒中量表(NIHSS)评分和日常生活活动能力Barthel指数(Barthel)。结果:总有效率治疗组为91.43%,对照组为80.00%。2组相比差异显著(P<0.05)。NIHSS评分和Barthel指数治疗后2组均明显改善(P<0.05),但治疗组改善更明显(P<0.05)。结论:早期应用阿加曲班联合参芎葡萄糖能提高临床有效率,改善进展性脑梗死的神经功能缺损和日常生活能力。
Abstract:
Objective: To investigate clinical effects of argatroban and ShenXiong glucose in treating progressive cerebral infarction. Methods: All 70 patients were randomly allocated into the treatment group and the control group, the treatment group accepted routine treatment, argatroban and ShenXiong glucose, and the control group routine treatment, one course of the treatment was 14 days. The scales of NIHSS, daily living ability and Barthel index of both groups were observed before and after treating. Results: Total effective rate of the treatment group was 91.43%, higher than 80.00% of the control group, the difference was significant (P<0.05). NIHSS scales and Barthel indexes were improved significantly after treating (P<0.05), and the improvement of the treatment group was more significant (P<0.05). Conclusion: Argatroban applied in the early time and ShenXiong glucose could improve clinical effective rate, improve neurologic impairment and daily living ability.

相似文献/References:

[1]张永全,张惠玉,仝树坡,等.急性脑梗死肝阳暴亢证患者血脂及经颅多普勒检查结果的相关性研究[J].西部中医药,2011,24(11):38.
[2]朱晓娜,李天浩.调脂柔脉颗粒治疗动脉粥样硬化性脑梗死的疗效评价[J].西部中医药,2012,25(10):77.
 ZHU Xiao-na,LI Tian-hao.Evaluation on Clinical Efficacy of TiaoZhi RouMai Granules in Treating Atherosclerotic Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2012,25(02):77.
[3]康庄.自拟中风活血化痰汤对急性脑梗死患者血清NSE、BDNF 水平的影响[J].西部中医药,2013,26(02):22.
 KANG Zhuang.Effects of Self-made ZhongFeng HuoXue HuaTanTang on Contents of Serum NSE and BDNF in Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2013,26(02):22.
[4]姚志瑞,焦富成,李霞.庆阳市脑梗死患者危险因素筛查及中医体质学分析[J].西部中医药,2013,26(09):53.
 YAO Zhirui,JIAO Fucheng,LI Xi.TCM Constitutions and Risk Factor Screening of Patients Suffering from Cerebral Infarction from Qingyang Municipality[J].Western Journal of Traditional Chinese Medicine,2013,26(02):53.
[5]刘晓花.中医康复护理与常规内科护理对脑梗死患者功能康复的效果观察[J].西部中医药,2013,26(10):117.
 LIU Xiaohua.Observation on Therapeutic Effects of TCM Rehabilitation Care and Routine Care on Functional Rehabilitation of the Patients with Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2013,26(02):117.
[6]梁建,刘国华,李水桥,等.红花黄色素联合依达拉奉治疗急性脑梗死临床观察[J].西部中医药,2014,27(03):105.
 LIANG Jian,LIU Guohua,LI Shuiqiao,et al.Clinical Observation on Carthamin Yellow Combined with Edaravone in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(02):105.
[7]祁瑞芳.同型半胱氨酸、超敏C-反应蛋白在2型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(04):136.
 QI Ruifang.Diagnostic Value of Homocysteine and High Sensitivity C-Reactive Protein in Predicting Type 2 Diabetes Mellitus Complicated with Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(02):136.
[8]祁瑞芳.同型半胱氨酸、超敏 C- 反应蛋白在 2 型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(08):152.
[9]王晓怀,寇嘉宁,潘文,等.黄芪注射液治疗脑梗死的Meta分析[J].西部中医药,2014,27(10):67.
[10]魏小年,师仰宏.醒脑静注射液治疗急性脑梗死50例[J].西部中医药,2014,27(10):88.

备注/Memo

备注/Memo:
收稿日期:2013-08-23作者简介:焦富成(1979—),男,主治医师。研究方向:神经内科常见病的诊治。
更新日期/Last Update: 2014-02-15